D-0515-2017 Class II Terminated
FDA drug recall D-0515-2017 was initiated by Sandoz Inc on Feb 10, 2017 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Oct 24, 2017).
Recall details
- Product Type
- Drugs
- Report Date
- Mar 15, 2017
- Initiation Date
- Feb 10, 2017
- Termination Date
- Oct 24, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Pioglitazone and Glimepiride Tablets, USP, 30 mg/4 mg, 30 count bottles, Rx only, Manufactured by Lek Pharmaceuticals d.d., Verovskova Ulica 57, Ljubljana, - SI-1526, Slovenia --- NDC 0781-5635-31
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide
Code information
Lot FY3669 with expiry 11/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0515-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026